logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tony Mok

the chinese university of hong kong
H指数:131
被引数:10.6万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial

撤稿说明：非小细胞肺癌的日间免疫化疗：一项随机III期试验

Nature Medicine
IF50
2026-06-240
PRE
Zhe Huang; Liang Zeng; Zhaohui Ruan; Qun Zeng; Huan Yan; Wenjuan Jiang; Yi Xiong; Chunhua Zhou; Haiyan Yang; Li Liu; Jiacheng Dai; Nachuan Zou; Shidong Xu; Ya Wang; Zhan Wang; Jun Deng; Xue Chen; Jing Wang; Hua Xiang; Xiaomei Li; Boris Duchemann; Guoqiang Chen; Yang Xia; Tony Mok; Christoph Scheiermann; Francis Lévi; Nong Yang; Yongchang Zhang
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial

非小细胞肺癌的日间免疫化疗: 一项随机3期试验

Nature Medicine
IF50
2026-02-020
PRE
Zhe Huang; Liang Zeng; Zhaohui Ruan; Qun Zeng; Huan Yan; Wenjuan Jiang; Yi Xiong; Chunhua Zhou; Haiyan Yang; Li Liu; Jiacheng Dai; Nachuan Zou; Shidong Xu; Ya Wang; Zhan Wang; Jun Deng; Xue Chen; Jing Wang; Hua Xiang; Xiaomei Li; Boris Duchemann; Guoqiang Chen; Yang Xia; Tony Mok; Christoph Scheiermann; Francis Lévi; Nong Yang; Yongchang Zhang
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib

失败模式、局部治疗的影响以及接受一线奥希替尼治疗的晚期EGFR突变阳性非小细胞肺癌患者中长期应答者的特征

Lung Cancer
IF4.4
2025-11-010
PRE
Allen C.C. Chen; Florence S.T. Mok; Wesley Wong; Benjamin H.W. Lam; David Johnson; Matthew M.P. Lee; Landon L. Chan; Frankie Mo; Kevin K.S. Mok; Olivia H. Chen; Kirsty Lee; Herbert H.F. Loong; K.C. Lam; Kelvin Yan; Tony S.K. Mok; Molly S.C. Li
Establishing the China–UK Cancer Prevention and Control Alliance

建立中英癌症预防与控制联盟

lancet oncology
IF0
2025-09-010
PRE
Jun Ma; David Kerr; Yuankai Shi; Charles Swanton; Tony Mok; Rebecca Fitzgerald; Rui-Hua Xu; Richard Cowan; Rong Lin; Mark Lawler; Gao-Jun Teng; Tim Eisen; Molly Li; Maria Kyrgiou; Fanny Wai San Ko; Mark Middleton; Binghe Xu; Eric Aboyage; Dan Xiao; Yi-Long Wu; Arnie Puroshotham; Li Yang; Daiming Fan
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial

Adagrasib 与多西他赛在 KRASG12C 突变非小细胞肺癌中的比较（KRYSTAL-12）：一项随机、开放标签、III 期临床试验

lancet
IF0
2025-08-070
PRE
Fabrice Barlesi; Wenxiu Yao; Michaël Duruisseaux; Ludovic Doucet; Aitor Azkárate Martínez; Vanesa Gregorc; Oscar Juan-Vidal; Shun Lu; Charlotte De Bondt; Filippo de Marinis; Helena Linardou; Young-Chul Kim; Robert Jotte; Enriqueta Felip; Giuseppe Lo Russo; Martin Reck; Mary F Michenzie; Wenjing Yang; Julie N Meade; Beata Korytowsky; Tony S K Mok
Durvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic non-small-cell lung cancer: outcomes by tumor mutational burden in POSEIDON

度伐利尤单抗联合或不联合特瑞普利单抗，与化疗联合用于一线治疗转移性非小细胞肺癌：POSEIDON研究中根据肿瘤突变负荷的结局

ESMO OPEN
IF8.3
2025-05-010
OA
Peters, S.; Oliner, K. S.; Hernault, A. l '; Ratcliffe, M.; Madison, H.; Lai, Z.; Stewart, R.; Mann, H.; Lowery, C.; Garon, E. B.; Mok, T.; Johnson, M. L.
Lung cancer research and treatment: global perspectives and strategic calls to action

肺癌研究与治疗: 全球视角与战略行动呼吁

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Meyer, M. -l.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. -c.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; Forde, P. M.; Gray, J.; Gros, L.; Halmos, B.; Herbst, R.; Jaenne, P. A.; Johnson, B. E.; Kelly, K.; Leighl, N. B.; Liu, S.; Lowy, I.; Marron, T. U.; Paz-Ares, L.; Rizvi, N.; Rudin, C. M.; Shum, E.; Stahel, R.; Trunova, N.; Bunn, P. A.; Hirsch, F. R.
Patterns of disease progression and efficacy of local ablative therapy among patients with metastatic EGFR-mutation positive non-small cell lung cancer treated with fi rst-line osimertinib

携带EGFR突变阳性的转移性非小细胞肺癌患者接受一线奥希替尼治疗后，疾病进展模式和局部消融治疗效果。

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Chen, C. C. A.; Chen, O. H.; Mok, K.; Lam, K. C.; Lee, W. C. K.; Mok, S. T. F.; Ng, T. Y. J.; Johnson, D.; Chan, L. L.; Yan, K. C. K.; Wong, W.; Lam, B.; Lee, M. P.; Mok, T. S. K.; Li, S. C. M.
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer

简明语言总结: 劳拉替尼与克唑替尼在非小细胞肺癌中的CROWN研究的5年结果

FUTURE ONCOLOGY
IF2.6
2024-10-030
OAAI
Solomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.

研究方向

暂未获取到该数据
Y
Yi‐Long Wu
H 指数:135论文数:2,242被引数:11.1万
S
Solange Peters
H 指数:112论文数:941被引数:7.0万
J
James Chih‐Hsin Yang
H 指数:141论文数:1,223被引数:10.9万
E
Enriqueta Felip
H 指数:129论文数:1,499被引数:11.0万
B
Benjamin Solomon
H 指数:98论文数:825被引数:6.3万
H
Herbert H. Loong
H 指数:41论文数:319被引数:8,520
A
Anthony T.�C. Chan
H 指数:107论文数:759被引数:4.3万
K
Kenneth J. O’Byrne
H 指数:91论文数:1,173被引数:4.8万
S
Stephen L. Chan
H 指数:84论文数:739被引数:3.6万
L
Luis Paz‐Ares
H 指数:116论文数:1,392被引数:9.3万